PROVIDER PROFILE · NPI 1316975451
Marcia BroseMD
PRESCRIBING · PART D · 2024
Total Rx claims
665
Beneficiaries
—
Total drug cost
$7.9M
Distinct drugs
15
Brand share
60.8%
Top prescribed drugs
Lenvatinib Mesylate210 claims
Levothyroxine Sodium138 claims
Levothyroxine Sodium60 claims
Cabozantinib S-Malate49 claims
Amlodipine Besylate32 claims
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
CROSS-REFERENCE